China Pharma Holdings
CPHI
5 hedge funds and large institutions have $460K invested in China Pharma Holdings in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
17% less funds holding
Funds holding: 6 → 5 (-1)
40% less capital invested
Capital invested by funds: $767K → $460K (-$307K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$45.5K |
| 2 |
HF
HRT Financial
New York
|
+$42K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$18.5K |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$50.5K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$8K |
| 3 |
TI
tru Independence
Portland,
Oregon
|
-$8 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $266K | -$50.5K | -219 | -13% |
|
|
BCM
2
Bridgeway Capital Management
Houston,
Texas
| $86K | – | – | – |
|
|
HF
3
HRT Financial
New York
| $54K | +$42K | +182 | +153% |
|
|
4
Citadel Advisors
Miami,
Florida
| $36K | +$45.5K | +197 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $18K | +$18.5K | +80 | +500% |
|
|
TI
6
tru Independence
Portland,
Oregon
| – | -$8 | -25 | Closed |
|
|
TSS
7
Two Sigma Securities
New York
| – | -$8K | -24 | Closed |
|
CPHI Hedge Fund Activity: Q3 2020 in Review
5 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q3 2020, worth a combined $460K — down 40% from $767K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CPHI and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 2 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $45.5K. The largest seller was Renaissance Technologies, cutting an estimated $50.5K.
- 5 institutional investors held China Pharma Holdings (CPHI) as of Q3 2020, down from 6 in Q2 2020.
- Funds reported $460K of China Pharma Holdings stock for Q3 2020, down 40% quarter-over-quarter.
- 1 fund opened new China Pharma Holdings positions in Q3 2020 and 2 closed out, a net change of -1 holder.
- The largest China Pharma Holdings buyer in Q3 2020 was Citadel Advisors, an estimated $45.5K added.
- The largest China Pharma Holdings seller in Q3 2020 was Renaissance Technologies, an estimated $50.5K sold.
Based on aggregated 13F filings for Q3 2020.